1. Home
  2. Category
  3. Survivorship

Long-Term and Late Effects

Journal Club
Open Access Article

Update on Identifying and Managing Osteoporosis in Women With Breast Cancer

Deanna Sanchez Yamamoto
Pamela Hallquist Viale
CJON 2009, 13(5), E18-E29 DOI: 10.1188/09.CJON.E18-E29
Aromatase inhibitors (AIs) have become integral to the treatment of women with breast cancer and are the treatment of choice in postmenopausal women who have tumors that are estrogen receptor positive. The depletion of estrogen seen with AI therapy is significant and translates to beneficial tumor...
0
No votes yet
Read this Article
Supportive Care

Back Pain: Is It Spinal Cord Compression?

Marcelle Kaplan
CJON 2009, 13(5), 592-595 DOI: 10.1188/09.CJON.592-595
0
No votes yet
Read this Article
Article

Postmarketing Surveillance for Oncology Drugs

Pamela Hallquist Viale
Susan Moore
CJON 2008, 12(6), 877-886 DOI: 10.1188/08.CJON.877-886
Adverse effects of cancer therapies may occur more than three decades after drug administration. Continued vigilance in postmarketing use of oncology agents is necessary to accurately track adverse effects, update prescribing information, and alert healthcare providers in a timely manner. This...
0
No votes yet
Read this Article

Questions, Concerns or Requests

We're just a click away for assistance.